04/26/2017 - 2:48pm

With Kmart's new initiative, the cost for patients of epinephrine auto-injectors could be as low as $0 for some commercially insured patients, and $199.99 per two-pack for patients paying in cash.

04/26/2017 - 2:09pm

Each generic will be available in three dosage strengths. 

04/25/2017 - 9:23am

For its 2017 fiscal fourth quarter ended March 4, Rite Aid reported revenues of $8.5 billion and a net loss of $21.1 million. Its adjusted net loss came in at $3.2 million, which bested Wall Street estimates.

04/24/2017 - 6:01pm

The Dr. Reddy’s progesterone capsules — recently approved by the Food and Drug Administration — will be available in 100- and 200-mg dosage strengths. 

04/24/2017 - 5:54pm

The transaction is expected to close by early 2018 and to be accretive in 2018 to Fresenius Group net income and EPS, excluding integration costs.

04/21/2017 - 7:28pm

Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.

04/21/2017 - 6:33am

Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg are the generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 mg, 8 mg and 16 mg, originally marketed by Schering. 

04/20/2017 - 3:04pm

Drugs are used for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination.

04/20/2017 - 10:07am

Japanese generic pharmaceutical manufacturer Sawai Pharmaceutical will purchase the assets and plans a major expansion in the U.S. market.